By Rahul Koul
“ Biomanufacturing has shifted focus from just being efficient to staying ahead of the curve”
In an exclusive interview, Sachin Joshi, Managing Director & Founder, PharmNXT Biotech shares insights on the company’ s focus on innovation, key product offerings, upcoming initiatives, sustainability and future plans
By Rahul Koul
PharmNXT Biotech focuses on advanced bioprocessing solutions. What key industry challenges are you addressing?
At PharmNXT Biotech, we are tackling one of the most pressing cost drivers in biologics and generics manufacturing— the exorbitant cost of raw materials, exacerbated by India ' s 90 % import dependency on critical consumables, APIs and key starting materials. This reliance inflates production costs, extends lead times, and creates vulnerabilities in supply chain resilience. Our approach is twopronged: first, we have set up India ' s first integrated indigenous state-ofthe-art facility in Pune to produce high-quality bioprocessing consumables at par with global standards. This not only reduces costs but also strengthens India ' s supply chain independence. Second, we recognise that cost efficiency is not just about localized production; it is also about customization and scalability; we cater to the precise needs of our clients in terms of specifications.
Global companies often impose minimum order quantities( MOQs)
and associated costs, but we produce materials tailored to individual orders,
BioTech
BIOVOICENEWS. COM 33